Evidence-Based Medicine’s Success May Alter Definition Of Proprietary Data
This article was originally published in The Gray Sheet
Executive Summary
With more emphasis being placed on the use of clinical evidence to drive insurance coverage and treatment decisions, providers' information needs may force manufacturers to change their views on proprietary data
You may also be interested in...
House Bill Targets Imaging Payments To Help Fund Children’s Insurance
A rapidly moving Medicare bill puts imaging payments back in the crosshairs as the House looks for cost-saving measures to fund coverage of uninsured children and prevent massive cuts to physician payments
Public Registration Of Device Trials Increases 10-Fold In Two Years
Registration of medical device trials on a government Web site increased more than 10-fold in the past two years, and legislation moving through Congress is likely to expand that activity even further
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.